Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product, LuViva™, is a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, LuViva was able to detect cervical cancer up to two years earlier than conventional tests. LuViva is designed to provide an objective result at the point-of-care, thereby improving the management of cervical disease: www.guidedinc.com.

Company:

Guided Therapeutics, Inc.

Headquarters Address:

5835 Peachtree Corners East

Suite B

Norcross, GA 30092

Main Telephone:

770-242-8723

Website:

www.guidedinc.com

Ticker/ISIN:

GTHP(OTCQB)/US40171F1057

Type of Organization:

Public

Industry:

Medical Devices

Key Executives:

CEO: Gene Cartwright

COO: Mark Faupel

Investor Relations

Contact:

Mark Faupel

Phone:

770-242-8723

Email:

mfaupel@guidedinc.com